...acquire exclusive, worldwide rights to Bionure’s preclinical serum/glucocorticoid regulated kinase 2 (SGK2) agonists BN201 and BN119... ...“is about to enter the clinic” to treat optic neuritis associated with multiple sclerosis (MS). BN119... ...Inc. , San Francisco, Calif. Business: Other
Bionure Farma S.L.
Spiral Therapeutics Inc.
Serum/glucocorticoid regulated kinase 2 (SGK2)